The role of thrombolytic therapy in pulmonary embolism
نویسندگان
چکیده
منابع مشابه
Pulmonary embolism--the role of thrombolytic therapy in its management.
In massive pulmonary embolism where there may be evidence of right ventricular dysfunction and acute pulmonary hypertension, anticoagulation therapy alone may prove inadequate. In such situations use of thrombolytic agents produces an improvement in haemodynamics compared to anticoagulants alone, although studies to date have been too small to address the issue of mortality benefit. It would ap...
متن کاملPulmonary Embolism Thrombolytic Therapy of Pulmonary Embolism A Meta-Analysis
OBJECTIVES We sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). BACKGROUND Thrombolytic therapy is approved for the treatment of acute PE; however, the safety and efficacy of this therapy remain debated. METHODS A meta-analysis of randomized, controlled trials comparing thrombolytic agents with intravenous heparin in patients wit...
متن کامل[Thrombolytic therapy of acute pulmonary embolism].
Thrombolytic therapy accelerates the dissolution of acute pulmonary embolism and is potentially lifesaving. The goal of this article is to offer a critical analysis of the use of thrombolytic therapy in this setting. Guidelines have been written and modified and new ones have been published over the past several years. Although an evidence base exists, unanswered questions remain. Despite the p...
متن کاملThe role of thrombolytic therapy in the treatment of pulmonary embolism.
309 IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMAS: A RANDOMIZED TRIAL COMPARING VACOP-B (A = DOXORUBICIN) VS VICOP-B (I = IDARUBICIN). Marilena Bertini, Roberto Freilone, Barbara Botto, Roberta Calvi, Andrea Gallamini, Anna Maria Gatti, Anna Maria Liberati, Vittorio Meneghini, Ester Orlandi, Lorella Orsucci, Michele Pizzuti, Delia Rota Scalabrini, Flavia Salvi, Giuseppe Todeschini, U...
متن کاملThe uncertain role of thrombolytic therapy in the treatment of pulmonary embolism.
IED20006 THE FIRST clinical report of the use of a thrombolytic agent (streptokinase) to treat acute pulmonary embolism (PE) appeared in 1964,1 and the first randomized clinical trial comparing urokinase plus heparin with heparin alone was published in 1970.2 A randomized clinical trial comparing urokinase to streptokinase in the treatment of PE was published in 1974.3 The first report of a thi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2015
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2014-08-559278